| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 15,525 | 17,152 | 21,266 | 24,433 | | Cost of Revenue | 47,703 | (18,977) | 18,977 | 72,959 | | | Gross Profit | (32,179) | 36,128 | 2,289 | (48,526) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (32,186) | 36,418 | 2,278 | (48,607) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 89 | 71 | 108 | 217 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (82) | (361) | (96) | (136) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2 | 8 | 4 | (1,808) | | Earnings Before Interest And Taxes | (80) | (353) | (92) | (1,944) | | Interest Expense | 56 | 51 | 58 | 62 | | Income Before Tax | (136) | (405) | (150) | (2,006) | | Income Tax Expense | (30) | (120) | (35) | (655) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (106) | (285) | (115) | (1,351) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (106) | (285) | (115) | (1,351) | | Preferred Stock And Other Adjustments | (4) | (4) | (4) | (4) | | | Net Income Applicable To Common Shares | ($110) | ($288) | ($119) | ($1,355) |
|
0.10% Nasdaq 
0.19%
Income Statement
